U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06920056) titled 'A Study of BGM0504 in Overweight or Obese Participants' on March 27.
Brief Summary: The purpose of the study is to evaluate the influence of BGM0504 injection on gastric emptying and Pharmacokinetics of metformin and warfarin in overweight or obese participants
Study Start Date: March 24
Study Type: INTERVENTIONAL
Condition:
Overweight or Obese
Intervention:
DRUG: Paracetamol
oral, postprandial
DRUG: Metformin Hydrochloride
Oral , Fasting
DRUG: Warfarin
Oral , Fasting
DRUG: BGM0504
Administered SC
Recruitment Status: RECRUITING
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Published by HT Digital Content Serv...